Decode Complex Diseases, Enabling Personalized Diagnostics, Cancer Genomics Profiling, Infectious Disease Tracking, And Biomarker Discovery.
Precision
Medicine
Dementia
Biomarkers
Rare
Disease
Sequencing
Cancer
Genetic
Testing
Cancer Genetic Testing
International DNA
Medical Laboratory (iDNA)
– a cutting-edge medical molecular laboratory
dedicated to advancing precision diagnostics and research. Equipped with state-of-the-art technologies, including Next-Generation Sequencing, DNA microarrays, and single-molecule array platforms, we deliver high-throughput genomic and molecular analyses with unmatched accuracy.
Partner with us
transforming insights into actionable outcomes for improved patient care.
Committed to innovation and quality, we adhere to rigorous standards to ensure reliable results for clinical diagnostics, translational research, and therapeutic development. We empower precision medicine and disease diagnosis, transforming insights into actionable outcomes for improved patient care.
International DNA
Medical Laboratory
iDna
MediRight Pharmacogenetic
(PGx) Testing
- Psychiatric Profile
CYP2B6, CYP2C9, CYP2C19, CYP2D6, CYP3A4, HLA-A, HLA-B - Cardiac Profile
CYP2C9, CYP2C19, VKORC1, SLCO1B1, ABCG2, APOE
- Eliminates the need for trial and error by eliminating the need for using generalized guidelines for drug choice and dosing and allowing individualized drug regimen
- Increases therapeutic success and decreases the risk of adverse drug reactions by ensuring the right dosage for each individual
- Decreases overall time and psychic cost, which in turn increases patient’s satisfaction and adherence to treatments
AlzDx Blood Biomarker Test for Dementia
Turn Blood into Answers: Plasma Markers – Redefining Dementia Diagnosis
The AlzDx blood Dementia Biomarker Panel is a cutting-edge, minimally invasive diagnostic tool designed to detect and monitor key pathological processes in neurodegenerative disorders. The panel provides a comprehensive assessment of amyloid/tau pathology, neuroinflammation, and axonal injury, enabling precise clinical insights with a simple blood test.
- AlzDx-III : p-Tau217, GFAP, NfL
- AlzDx-III : GFAP, NfL
- AlzDx-I : p-Tau217
- AlzDx-IV : p-Tau217, GFAP, NfL, APOE genotyping
*P-Tau217 : phosphorylated Tau-217
GFAP : Glial Fibrillary Acidic Protein
NfL : Neurofilament Light Chain.
- Non-invasive: Avoids the need for cerebrospinal fluid (CSF) sampling or advanced imaging.
- High Sensitivity & Specificity: Validated immunoassay technology ensures reliable detection of low biomarker concentrations.
- Multidimensional Insights: Captures distinct aspects of neurodegeneration for accurate differential diagnosis.
- Longitudinal Monitoring: Ideal for tracking disease progression and therapeutic response.
APOE Genotyping
- APOE genetic risk of Alzheimer’s Disease Risk
- APOE genetic risk of Cardiovascular Disease & Lipid Metabolism
- Identifies the presence of the APOE ε4 allele, the most significant genetic risk factor for late-onset Alzheimer’s disease.
- Helps individuals and families understand genetic susceptibility, enabling proactive health planning.
- Provide drug guidance and help clinicians to select drugs for patients
- Detects alleles linked to elevated LDL cholesterol and atherosclerosis risk.
- Supports early intervention strategies, such as dietary changes or lipid-lowering therapies, to reduce cardiovascular risks.
- Provides clarity for unexplained lipid abnormalities, guiding targeted treatment plans.
Targeted Gene Sequencing / WES
Unravel the Rare, Simplify the Diagnosis : Gene Sequencing – Transforming Diagnostic Challenges into Answers
We empower clinicians with cutting-edge next-generation sequencing (NGS) solutions to accelerate the diagnosis of rare genetic diseases. Our gene sequencing services are designed to identify elusive genetic variants, providing clarity for patients and families navigating the complexities of rare disorders.
- Disease specific panels available
- Tailor-made panels based on given diseases
- Tailor-made panels based on genes provided
- Whole Exome Sequencing (WES)
Contact us today to discuss your case and discover how our genetic sequencing services can shorten the diagnostic odyssey. Professional medical genetic support will be offered to clinicians.
1.High Diagnostic Yield
- Identifies pathogenic variants in known disease-associated genes, even in genetically heterogeneous conditions.
- Resolves undiagnosed cases where traditional methods fail.
2.Comprehensive Yet Focused Analysis
- Targeted Panels: Analyze specific genes linked to suspected conditions, reducing noise and cost.
- WES: Examines ~20,000 protein-coding genes, capturing both known and novel variants.
3.Family Testing & Cascade Screening
- Enables proactive monitoring or early interventions in family members.
Hereditary Cancer Testing
See Risk Before It Strikes – Hereditary Cancer Testing Turns Uncertainty into Action.
Discover the inherited genetic risk for cancer and take proactive control of the health with our comprehensive hereditary cancer genetic testing panel. Designed to identify inherited mutations linked to 26 cancer types, this test provides actionable insights to guide personalized prevention, early detection, and informed medical decisions. Professional medical genetic support will be offered.
- BRCA1 & 2 genes Test
- Single-Cancer Test
- Full 26-Panel Test
1. Early Risk Identification – Detects inherited mutations linked to elevated cancer risks, enabling proactive screening and prevention.
2. Family Health Empowerment – Identifies at-risk relatives, allowing early interventions for entire families.
You must be logged in to post a comment.